Make a Gift
College of Health Sciences
Healthcare Professionals
Volunteering
MyChart Login
Clinical Trials
Career Opportunities
Contact Us
≡
Medical Services
Find a Provider
Patients & Visitors
Classes & Events
Clinical Trials
Contact a Patient
Dining
Donate Blood
Parking
Patient Feedback
Pay Bills Online
Pricing Transparency
Visiting Hours
MyChart Login ›
Report Sexual Misconduct ›
Locations
News & Blog
News & Stories
Live Well Blog
Live Well Magazine
Webinars
Subscribe to Newsletter
Coronavirus FAQ
Events
About Us
About UCI Health
340B Program
Classes & Events
Community Health
Compliance
Contact Us
Giving
Human Resources
News
Nondiscrimination
Planning Administration
Publications
Quality & Safety
Virtual Tour
Volunteering
Site Search
Site Search
Home
>
Clinical Trials
>
Cancer Clinical Trial
>
Brain and Nervous System
>
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of (ERC1671/ GM-CSF / Cyclophosphamide) + Bevacizumab versus (Placebo Injection / Placebo pill) + Bevacizumab in the Treatment of Recurrent/Progressive, Bevacizumab Naïve Glioblastoma Multiforme and Gliosarcoma Patients (WHO Grade IV Malignant Gliomas)
Print
A
A
A
COVID-19 vaccine and protecting your health ›